Extract from the Register for Unitary Patent Protection

UP About this file: EP4087486  C0

EP4087486 - SYSTEMS, METHODS, AND DEVICES FOR MEDICAL IMAGE ANALYSIS, DIAGNOSIS, RISK STRATIFICATION, DECISION MAKING AND/OR DISEASE TRACKING [Right-click to bookmark this link]
StatusUnitary effect registered
Database last updated on 09.04.2026
FormerRequest for unitary effect filed
Status updated on  10.10.2025
Most recent event   Tooltip09.01.2026New entry: Payment of renewal fee 
Proprietor(s)For all participating member states
Cleerly, Inc.
1099 18th Street, Suite 2860
Denver, Colorado 80202 / US
[2025/52]  
Inventor(s)01 / MIN, James K.
Denver, Colorado 80202 / US
02 / EARLS, James P.
Denver, Colorado 80202 / US
03 / RODRIGUES MARQUES, Hugo Miguel
Denver, Colorado 80202 / US
 [2025/35]
Former [2022/46]01 / MIN, James K.
101 Greenwich Street
New York, New York 10006 / US
02 / EARLS, James P.
101 Greenwich Street
New York, New York 10006 / US
03 / RODRIGUES MARQUES, Hugo Miguel
101 Greenwich Street
New York, New York 10006 / US
Representative(s)Grünecker Patent- und Rechtsanwälte PartG mbB
Leopoldstraße 4
80802 München / DE
[2025/52]
Application number, filing date21738911.305.01.2021
[2022/46]
WO2021US12218
Procedural languageEN
(Principal) place of business   Tooltip
on the date of filing
 Principal place of businessTooltip
Unitary Patent Protection09.10.2025Date of request for unitary effect [2025/46]
19.11.2025Decision on the request for unitary effect:  Positive [2025/52]
19.11.2025Date of registration  [2025/52]
10.09.2025Date of legal effect  [2025/52]
Member States covered by Unitary  Tooltip
Patent Protection
19.11.2025AT, BE, BG, DE, DK, EE, FI, FR, IT, LT, LU, LV, MT, NL, PT, RO, SE, SI  [2025/52]
PublicationType: B1 Patent specification 
No.:EP4087486
Date:10.09.2025
Language:EN
[2025/37]
Renewal fees paidRenewal fee
07.01.2026Renewal fee unitary effect year  06
The European Patent Register provides the information on unitary patent protection required under R. 16(1) UPR. "Status" and "Most recent event" are not entries required under R. 16(1) UPR and should therefore be regarded as additional information only.

The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes. Please refer to the relevant national patent authority for SPC data.